期刊文献+

新型抗真菌药阿尼芬净的研究进展 被引量:9

Research Progress of Anidulafungin as New Antifungal Agent
下载PDF
导出
摘要 阿尼芬净是一种新型的棘白菌素类抗真菌药,能够抑制真菌细胞壁中1,3-β-D-葡聚糖的合成,对真菌有较高的特异性;对于念珠菌属以及曲霉菌属均有良好的抗菌作用,且安全性较高。介绍了阿尼芬净的作用机制、抗菌活性、药动学和临床评价。 Anidulafungin is a new echinocandin antifungal agent.It not only acts by inhibiting the production of 1,3-β-D-glucan which is a key component in fungal cell wall synthesis and has selective toxicity to fungi,but also has potent activity against candida and aspergillus species,and has proved to be quite safe.To introduce the mechanism,antifungal activity,pharmacokinetics and clinical therapeutics of anidulafungin.
作者 谢新宇
出处 《河北化工》 2011年第5期33-34,57,共3页 Hebei Chemical Industry
关键词 阿尼芬净 作用机制 抗菌活性 药动学 临床评价 anidulafungin mechanism antifungal activity pharmacokinetics clinical evaluation
  • 相关文献

参考文献9

  • 1Debono M,Gordee R S.Antibiotics that inhibit fungal cell wall development[J].Annu Rev Microbiol,1994,48(12):471-497.
  • 2Murdoch D,Ptosker G L.Anidulafungin[J].Drug,2004,64(19):2249-2 258.
  • 3Espinel-Ingroff A.Invitroantifungal activities of anidulafungin and micafungin,licensed agents and the investigational triazole pesaconazole as determined by NCCLS methods for 12 052 fungal isolates:review of the Iiterature[J].Rev Iberoam Mico,2003,20(4):121-136.
  • 4Petraitiene R,Petraitis V,Groll AH,et al.Antifungal activity of LY303366,a novel echinocandin B,in experimental disseminated candidiasis in rabbits[J].Antimicrob Agents Chemother,1999,43(9):21478-2155.
  • 5Petraitis V,Petraitiene R,Groll AH,et al.Antifungal efficacy,safety,and single-dose pharmacokinetics of LY303366,a novel echinocandin B,in experimental pulmonary aspergillosis in persistently neutropenic rabbits[J].Antimicrob Agents Chemother,1998,42(11):2898-2 905.
  • 6Vazquez J A,Sobel J D.Anidulafungin:A Novel Echinocandin[J].Clin Infect Dis,2006,42(15):215-222.
  • 7Stogniew M,Pu F,Henkel T.Antifungal biotransformatation in humans is by degradation not metabolism[C] // Program and abstracts of 13rd European congress of clinical microbiology and infectious diseases,2003:1223.
  • 8Krause D,Simjee A E,Van Rensburg C,et al.A randomized,doubleblind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis[J].Clin Infect Dis,2004,39(6):770-775.
  • 9Krause D,Reinhardt J,Vazquez JA,et al.Phaes Ⅱ.randomized dose-ranging study evaluating the safety and efficacy of anidulafungin in invasive candidiasis and candidemia[J].Antimicrob Agents Chemother,2004,48(6):2 012-2 014.

同被引文献91

引证文献9

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部